CFH and dense deposit disease: Acquired deficiency or inactivating mutations of these soluble regulators, notably factor H (CFH), have been associated with a spectrum of glomerular disease, from Dense-deposit disease at one end to atypical hemolytic-uremic syndrome at the other [12].